Drug resistance in cancer immunotherapy: new strategies to improve checkpoint inhibitor therapies

Recent advances in pharmacological immune modulation against tumor cells has dramatically changed the paradigm of cancer treatment. Checkpoint inhibitor therapy is a form of cancer immunotherapy already in clinical setting but also under active basic and clinical investigation. Nevertheless, some pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez-Pascual, Jesus, Ayuso-Sacido, Angel, Belda-Iniesta, Cristobal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019209/
https://www.ncbi.nlm.nih.gov/pubmed/35582274
http://dx.doi.org/10.20517/cdr.2019.61

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019209/
https://www.ncbi.nlm.nih.gov/pubmed/35582274
http://dx.doi.org/10.20517/cdr.2019.61

Ejemplares similares